Intuitive Surgical, Inc. (ISRG) Stock

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Intuitive Surgical, Inc. is led by CEO David J. Rosa, employs 15,638 people, headquartered in Sunnyvale, US, publicly traded since 2000.

Intuitive Surgical, Inc. (ISRG) stock trades at $353.10 with a market capitalization of $124.74B. The stock is valued at a price-to-earnings (P/E) ratio of 54.82, price-to-book of 9.13, price-to-sales of 13.96. Over the past 52 weeks the stock has ranged between $329.04 and $603.88, and currently trades 41.5% below its 52-week high.

On profitability, Intuitive Surgical, Inc. generates a return on equity (ROE) of 17.23%, above the typical market average, return on capital employed of 16.42%, an operating margin of 29.27%, a net profit margin of 28.15%.

In its most recent fiscal year, Intuitive Surgical, Inc. reported annual revenue of $10.1B, net profit of $2.9B, revenue has compounded at 18.2% a year over the last five years, profit at 21.9% a year. Profit growing faster than revenue points to expanding margins.

The balance sheet shows a debt-to-equity ratio of 0.02 — a conservative balance sheet with little leverage risk, a current ratio of 4.88, total assets of $20.6B, $3.4B in cash and equivalents.

ISRG has an average daily trading volume of 2,877,482 shares, a beta of 1.45 (more volatile than the overall market).

Official website: www.intuitive.com